Navigation Links
HIV Treatment Said to Increase Heart Attack Risk

A common treatment option for HIV patients is associated with an increased risk for a heart attack, according to a new study. However, researchers say the benefit of the treatment outweighs the risk of a //heart attack for most patients.

Combination antiretroviral therapy substantially improves the prognosis of HIV-infected patients at risk for AIDS. Before this therapy was available, the annual mortality rate among patients with HIV infection exceeded 20 percent.

In the current research, the mortality rate was 2 percent. While the benefits of combination antiretroviral therapy are clear, there is a concern about the treatment being associated with adverse side effects. These side effects include high cholesterol and triglycerides, insulin resistance and diabetes. These problems can lead to cardiovascular problems.

Researchers in Denmark conducted a study to determine if exposure to combination antiretroviral treatment increases the risk of a heart attack. They looked at information on more than 23,000 patients from 11 previous studies. They collected follow-up information on the patients about their HIV and if they had suffered a heart attack.

Researchers collected data over a period of 36,199 person-years. They found 126 patients had a heart attack. They say the incidence of a heart attack increased with longer exposure to combination antiretroviral therapy. They also say factors such as older age, current or former smoking, previous cardiovascular disease and male sex also increased the risk for a heart attack. Furthermore, a higher cholesterol level, a higher triglyceride level and diabetes were associated with an increased risk for a heart attack.

Investigators conclude combination antiretroviral therapy was independently associated with a 26-percent increase in the rate of a heart attack. However, they point out the risk has to be balanced against the benefits from the antiretroviral treatment. They add tha t heart disease can take decades to develop, so further follow-up research is needed to determine the absolute risk of cardiovascular disease.


'"/>




Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... The freshly released app Smart ... to Smart Mart, customers can now order vegetable, fruit, snacks, dairy, or any ... find clothing at discounted prices. Apart from this, Smart Mart has emphasized upon ...
(Date:9/22/2017)... Greenwich, Connecticut (PRWEB) , ... September 22, 2017 ... ... to conquering Lyme and other tick-borne diseases through research, education and awareness, today ... , A noted immunologist and microbiologist, Dr. Sellati has more than 20 ...
(Date:9/21/2017)... ... 2017 , ... 38-Year-Old Plastic Surgeon Gill at Aesthetic Surgery Center is Saluted ... announce that Plastic Surgeon Kiranjeet Gill has been awarded as one of the 15th ... award that was started in 2003 to salute young achievers in Southwest Florida who ...
(Date:9/21/2017)... ... September 21, 2017 , ... SABRE is raising awareness ... September 11 to the end of November. , The Chicago, Illinois, based self-defense brand ... and teach them about the ease of taking their personal safety into their own ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and ... while staying in compliance with FDA rules. , The FDA has issued two ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 8, 2017 ... Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 th .The ... free MRI brain scans to the public.Where:  BTF,s ... at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... RANCHO MIRAGE, Calif. , Sept. 7, 2017  For nearly two ... and service in the Assisted Reproduction Insurance industry. Today, New Life Agency ... expensive fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology: